Filing Details

Accession Number:
0001567619-20-015578
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-14 18:30:59
Reporting Period:
2020-08-12
Accepted Time:
2020-08-14 18:30:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD Biological Products, (No Disgnostic Substances) (2836) 472029180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800670 Barbara Weber C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-12 1,667 $1.12 3,475 No 4 M Direct
Common Stock Disposition 2020-08-12 1,667 $28.00 1,808 No 4 S Direct
Common Stock Acquisiton 2020-08-13 333 $1.12 2,141 No 4 M Direct
Common Stock Disposition 2020-08-13 333 $28.00 1,808 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-12 1,667 $0.00 1,667 $1.12
Common Stock Stock Option (Right to Buy) Disposition 2020-08-13 333 $0.00 333 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,158 2028-04-19 No 4 M Direct
28,825 2028-04-19 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. Includes 1,808 Restricted Stock Units.
  3. This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the "Vesting Commencement Date") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date.